These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21701224)

  • 21. Clarithromycin treatment in preterm infants: a pilot study for prevention of feeding intolerance.
    Gokmen T; Ozdemir R; Bozdag S; Oguz SS; Erdeve O; Uras N; Dilmen U
    J Matern Fetal Neonatal Med; 2013 Oct; 26(15):1528-31. PubMed ID: 23570248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin for treatment of feeding intolerance in preterm infants.
    Su BH; Lin HC
    J Pediatr; 2007 Feb; 150(2):e30; author reply e31. PubMed ID: 17236878
    [No Abstract]   [Full Text] [Related]  

  • 23. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?
    Patole SK; Almonte R; Kadalraja R; Tuladhar R; Muller R; Whitehall JS
    Int J Clin Pract; 2000 Oct; 54(8):504-8. PubMed ID: 11198727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient.
    Fraser RJ; Bryant L
    Nutr Clin Pract; 2010 Feb; 25(1):26-31. PubMed ID: 20130155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
    Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
    Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of a standardised feeding regimen during a clinical trial in preterm neonates.
    Patole SK; Kadalraja R; Tuladhar R; Almonte R; Muller R; Whitehall JS
    Int J Clin Pract; 2000 Sep; 54(7):429-31. PubMed ID: 11070566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Any news from the prokinetic front?
    Deane AM; Chapman MJ; Abdelhamid YA
    Curr Opin Crit Care; 2019 Aug; 25(4):349-355. PubMed ID: 31247631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisapride may improve feeding tolerance of preterm infants: a randomized placebo-controlled trial.
    Kohl M; Wuerdemann I; Clemen J; Iven H; Katalinic A; Moeller JC
    Biol Neonate; 2005; 88(4):270-5. PubMed ID: 16113520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prokinetic therapy for feed intolerance in critical illness: one drug or two?
    Nguyen NQ; Chapman M; Fraser RJ; Bryant LK; Burgstad C; Holloway RH
    Crit Care Med; 2007 Nov; 35(11):2561-7. PubMed ID: 17828038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythromycin as a prokinetic agent in preterm infants.
    Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risks and benefits of cisapride in premature neonates, infants, and children.
    Lander A; Desai A
    Arch Dis Child; 1998 Dec; 79(6):469-70. PubMed ID: 10210987
    [No Abstract]   [Full Text] [Related]  

  • 32. How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
    Asai T
    Crit Care Med; 2007 Feb; 35(2):650-1. PubMed ID: 17251716
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance.
    Ng YY; Su PH; Chen JY; Quek YW; Hu JM; Lee IC; Lee HS; Chang HP
    Pediatr Neonatol; 2012 Feb; 53(1):34-40. PubMed ID: 22348492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromycin and position facilitated placement of postpyloric feeding tubes in burned patients.
    Komenaka IK; Giffard K; Miller J; Schein M
    Dig Surg; 2000; 17(6):578-580. PubMed ID: 11155002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythromycin as a prokinetic: is the overall benefit corroborated?
    Singh NK
    Crit Care Med; 2007 May; 35(5):1446; author reply 1446-7. PubMed ID: 17446761
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastric emptying: Trial of nasointestinal feeding versus nasogastric feeding plus prokinetics.
    Taylor SJ; Allan K; McWilliam H; Manara A; Brown J; Greenwood R; Toher D
    Clin Nutr ESPEN; 2016 Aug; 14():1-8. PubMed ID: 28531392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-dose oral erythromycin on gastric aspirates in ventilated neonates less than 32 weeks of gestation. Preliminary results.
    Dellagrammaticas HD; Iacovidou N; Megaloyanni E; Papadimitriou M; Kapetanakis J
    Biol Neonate; 2002; 81(3):213-6. PubMed ID: 11937729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit].
    Lu NF; Zheng RQ; Lin H; Yang DG; Chen QH; Shao J; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jan; 22(1):36-9. PubMed ID: 20092709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risks and benefits of cisapride.
    Cairns P
    Arch Dis Child; 1999 May; 80(5):493. PubMed ID: 10523247
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance.
    Nguyen NQ; Ching K; Fraser RJ; Chapman MJ; Holloway RH
    Intensive Care Med; 2008 Jan; 34(1):169-73. PubMed ID: 17701160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.